Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Arepanrix Co-administered with Seasonal Flu Vaccine
NCT00985673Phase 2Completed
- Sponsor
- GSK
- Start
- Oct 2009
- Primary completion
- Dec 2009
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines, Cancer Vaccines
- Countries
- 2
01
Overview
A Phase 2 trial of recombinant influenza ha vaccine (h5n1) in influenza A H1N1 infection (H1N1), sponsored by GSK. Started Oct 2009; status: completed.
02
Drugs
recombinant influenza ha vaccine (h5n1)
03
Conditions
influenza A H1N1 infection (H1N1)
Beyond the preview
Go deeper on NCT00985673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00985673.